BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/20/2023 11:28:13 AM | Browse: 105 | Download: 186
 |
Received |
|
2022-12-13 02:15 |
|
Peer-Review Started |
|
2022-12-13 02:19 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-02-08 07:27 |
|
Revised |
|
2023-03-14 18:28 |
|
Second Decision |
|
2023-04-14 03:18 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-04-14 09:45 |
|
Articles in Press |
|
2023-04-14 09:45 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-04-12 19:41 |
|
Typeset the Manuscript |
|
2023-06-13 07:25 |
|
Publish the Manuscript Online |
|
2023-06-20 11:28 |
| ISSN |
2222-0682 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Noncommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
Copyright: © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Therapeutic potential of curcumin and its nanoformulations for treating oral cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Diptasree Mukherjee and Arunkumar Krishnan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Arunkumar Krishnan, MBBS, Doctor, Research Fellow, Research Scientist, Department of Medicine Section of Gastroenterology and Hepatology, West Virginia University School of Medicine, PO Box 9161, 5th Floor HSC, Room 5500
, Morgantown, WV 26505, United States. dr.arunkumar.krishnan@gmail.com |
| Key Words |
Oral cancer; Oral squamous cell carcinoma; Analogues; Curcumin; Adjuvant therapy; Nanocurcumin; Curcumin nanoformulations; Curcumin analogues |
| Core Tip |
Oral cancer has a high disease burden worldwide. Oral squamous cell carcinoma is the most predominant subtype of oral cancer. The majority of oral cancers present at an advanced stage and are associated with a poor prognosis. Timely diagnosis and early treatment are critical to achieve a superior outcome. Surgery is the recommended treatment for oral cancer; other treatment modalities are radiotherapy with or without chemotherapy. Curcumin, a plant derivative, is one among the available adjuvant therapies that has been studied for its anticarcinogenic potential in the setting of various cancers. Curcumin has been proven to modulate intracellular signaling pathways that control cancer cell growth, inflammation, invasion, apoptosis, and cell death, with evidence supporting its use in cancer therapy. This review aims to summarize the molecular pathways involved in oral carcinoma pathogenesis, to explore different therapeutic interactions of curcumin, and to highlight the role of novel curcumin formulations in oral cancer treatment. |
| Publish Date |
2023-06-20 11:28 |
| Citation |
Mukherjee D, Krishnan A. Therapeutic potential of curcumin and its nanoformulations for treating oral cancer. World J Methodol 2023; 13(3): 29-45 |
| URL |
https://www.wjgnet.com/2222-0682/full/v13/i3/29.htm |
| DOI |
https://dx.doi.org/10.5662/wjm.v13.i3.29 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
